$ALXN Headlines Are consumers getting gouged o
Post# of 44830
Posted On: 12/17/2014 12:41:03 PM
$ALXN Headlines
Are consumers getting gouged on health care? 9:36 a.m. Nov. 22, 2014 - Russ Britt
Alexion Pharmaceuticals shares advance 5.3% 8:32 a.m. Oct. 23, 2014 - Sue Chang
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
S&P 500 ekes out another record close: stock market live blog recap 3:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 10:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 2:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 3:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 8:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 2:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 5:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 3:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 3:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 12:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 4:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 3:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 1:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 11:48 a.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 3:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 3:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 3:16 p.m. March 21, 2014 - Sue Chang
Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog 10:26 a.m. Today - Zacks.com
Alexion Announces New Share Repurchase Program of $500M - Analyst Blog 6:55 p.m. Dec. 16, 2014 - Zacks.com
Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog 6:15 p.m. Dec. 15, 2014 - Zacks.com
United Therapeutics: Will It Pass Peers In 2015? 5:11 p.m. Dec. 12, 2014 - Investors Business Daily
IBD 50: Growth Stocks Fight The Fight In Weak Tape 5:11 p.m. Dec. 12, 2014 - Investors Business Daily
The New #47 Most Shorted Nasdaq 100 Component: Alexion Pharmaceuticals 4:21 p.m. Dec. 11, 2014 - TheStreet.com
ChemoCentryx: Can It Break Into The Soliris Market? 3:08 p.m. Dec. 11, 2014 - Seeking Alpha
Are Investors Signaling Optimism in Biotechs Through Short Interest? 9:24 a.m. Dec. 10, 2014 - 247WallSt.com
Insider Trading Alert - PNW, BCEI And ALXN Traded By Insiders 12:28 p.m. Dec. 9, 2014 - TheStreet.com
Two Gauges That Point To Fund Buying In A Stock 5:18 p.m. Dec. 8, 2014 - Investors Business Daily
Weekly CFO Sells Highlight: Alexion Pharmaceuticals Inc, Equity Residential, Tableau Software Inc. 9:41 a.m. Dec. 8, 2014 - GuruFocus.com
Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY 9:37 a.m. Dec. 8, 2014 - GuruFocus.com
Inside The IBD 50: Challenging Time For Growth Stocks 5:54 p.m. Dec. 5, 2014 - Investors Business Daily
3 Growth Stocks In Buy Range After Recent Breakouts 5:41 p.m. Dec. 3, 2014 - Investors Business Daily
Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study - Analyst Blog 10:51 a.m. Dec. 3, 2014 - Zacks.com
Stock Market News for December 03, 2014 - Market News 10:10 a.m. Dec. 3, 2014 - Zacks.com
Today Alexion Pharmaceuticals (ALXN) Hits New Lifetime High 9:46 a.m. Dec. 3, 2014 - TheStreet.com
Meet 5 Big Caps Whose Earnings Are Expected To Surge 7:02 a.m. Dec. 3, 2014 - Investors Business Daily
Apple, Facebook: Jason Weiner Of Fidelity's View 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
Top Funds Gobble Up Tech And Medical Stocks 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
Alexion Announces $500 Million Share Repurchase Program 6:30 a.m. Dec. 15, 2014 - BusinessWire - BZX
X-Chem and Alexion Collaborate to Discover Novel Therapeutic Candidates to Treat Patients with Severe and Ultra-Rare Disorders 8:57 a.m. Dec. 11, 2014 - BusinessWire - BZX
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Myasthenia Gravis 4:15 p.m. Dec. 10, 2014 - BusinessWire - BZX
New Data Presented at ASH Annual Meeting Enhance Clinical Knowledge of aHUS and PNH and Underscore the Effectiveness of Soliris® (eculizumab) Treatment 9:00 p.m. Dec. 8, 2014 - BusinessWire - BZX
NICE Issues Final Positive Recommendation for National Commissioning of Soliris® (eculizumab) for All Patients with aHUS in England 4:46 a.m. Nov. 27, 2014 - BusinessWire - BZX
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Neuromyelitis Optica 6:30 a.m. Nov. 25, 2014 - BusinessWire - BZX
Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS Underscore the Effectiveness of Ongoing Soliris Treatment 10:00 a.m. Nov. 15, 2014 - BusinessWire - BZX
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global Operations Officer, in January 2015 6:30 a.m. Nov. 10, 2014 - BusinessWire - BZX
Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the Effectiveness of Soliris® (eculizumab) Treatment at ASH 2014 Annual Meeting 4:16 p.m. Nov. 6, 2014 - BusinessWire - BZX
Neurotrope Appoints Warren W. Wasiewski, M.D. as Executive Vice President, Development and Chief Medical Officer 8:30 a.m. Nov. 6, 2014 - PR Newswire - PRF
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Alexion Launches Every Day with HPP™ Campaign in Support of Hypophosphatasia (HPP) Awareness Week 4:51 p.m. Oct. 27, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 9:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
Researchers to Present Data on Soliris® (eculizumab) as a Treatment for Patients with aHUS at ASN 2014 Annual Meeting 4:15 p.m. Oct. 23, 2014 - BusinessWire - BZX
Collaborations, Dividends, New Drug Applications, and Technical Updates - Research Reports on Simon, Regions Financial, American Capital, CareFusion and Alexion 9:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Critical Alerts For Sears Holdings, JetBlue, Qlogic, Las Vegas Sands and Alexion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 15, 2014 - PR Newswire - PRF
Alexion Submits NDA in Japan for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:30 a.m. Oct. 15, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Third Quarter 2014 Results on Thursday, October 23, 2014 10:00 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Board of Directors Appoints New Chairman and Creates the New Position of Lead Independent Director 6:30 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Announces the Passing of Max Link, Ph.D., Chairman of the Company’s Board of Directors 4:00 p.m. Oct. 7, 2014 - BusinessWire - BZX
Are consumers getting gouged on health care? 9:36 a.m. Nov. 22, 2014 - Russ Britt
Alexion Pharmaceuticals shares advance 5.3% 8:32 a.m. Oct. 23, 2014 - Sue Chang
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
S&P 500 ekes out another record close: stock market live blog recap 3:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 10:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 2:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 3:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 8:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 2:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 5:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 3:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 3:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 12:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 4:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 3:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 1:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 11:48 a.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 3:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 3:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 3:16 p.m. March 21, 2014 - Sue Chang
Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog 10:26 a.m. Today - Zacks.com
Alexion Announces New Share Repurchase Program of $500M - Analyst Blog 6:55 p.m. Dec. 16, 2014 - Zacks.com
Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog 6:15 p.m. Dec. 15, 2014 - Zacks.com
United Therapeutics: Will It Pass Peers In 2015? 5:11 p.m. Dec. 12, 2014 - Investors Business Daily
IBD 50: Growth Stocks Fight The Fight In Weak Tape 5:11 p.m. Dec. 12, 2014 - Investors Business Daily
The New #47 Most Shorted Nasdaq 100 Component: Alexion Pharmaceuticals 4:21 p.m. Dec. 11, 2014 - TheStreet.com
ChemoCentryx: Can It Break Into The Soliris Market? 3:08 p.m. Dec. 11, 2014 - Seeking Alpha
Are Investors Signaling Optimism in Biotechs Through Short Interest? 9:24 a.m. Dec. 10, 2014 - 247WallSt.com
Insider Trading Alert - PNW, BCEI And ALXN Traded By Insiders 12:28 p.m. Dec. 9, 2014 - TheStreet.com
Two Gauges That Point To Fund Buying In A Stock 5:18 p.m. Dec. 8, 2014 - Investors Business Daily
Weekly CFO Sells Highlight: Alexion Pharmaceuticals Inc, Equity Residential, Tableau Software Inc. 9:41 a.m. Dec. 8, 2014 - GuruFocus.com
Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY 9:37 a.m. Dec. 8, 2014 - GuruFocus.com
Inside The IBD 50: Challenging Time For Growth Stocks 5:54 p.m. Dec. 5, 2014 - Investors Business Daily
3 Growth Stocks In Buy Range After Recent Breakouts 5:41 p.m. Dec. 3, 2014 - Investors Business Daily
Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study - Analyst Blog 10:51 a.m. Dec. 3, 2014 - Zacks.com
Stock Market News for December 03, 2014 - Market News 10:10 a.m. Dec. 3, 2014 - Zacks.com
Today Alexion Pharmaceuticals (ALXN) Hits New Lifetime High 9:46 a.m. Dec. 3, 2014 - TheStreet.com
Meet 5 Big Caps Whose Earnings Are Expected To Surge 7:02 a.m. Dec. 3, 2014 - Investors Business Daily
Apple, Facebook: Jason Weiner Of Fidelity's View 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
Top Funds Gobble Up Tech And Medical Stocks 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
Alexion Announces $500 Million Share Repurchase Program 6:30 a.m. Dec. 15, 2014 - BusinessWire - BZX
X-Chem and Alexion Collaborate to Discover Novel Therapeutic Candidates to Treat Patients with Severe and Ultra-Rare Disorders 8:57 a.m. Dec. 11, 2014 - BusinessWire - BZX
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Myasthenia Gravis 4:15 p.m. Dec. 10, 2014 - BusinessWire - BZX
New Data Presented at ASH Annual Meeting Enhance Clinical Knowledge of aHUS and PNH and Underscore the Effectiveness of Soliris® (eculizumab) Treatment 9:00 p.m. Dec. 8, 2014 - BusinessWire - BZX
NICE Issues Final Positive Recommendation for National Commissioning of Soliris® (eculizumab) for All Patients with aHUS in England 4:46 a.m. Nov. 27, 2014 - BusinessWire - BZX
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Neuromyelitis Optica 6:30 a.m. Nov. 25, 2014 - BusinessWire - BZX
Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS Underscore the Effectiveness of Ongoing Soliris Treatment 10:00 a.m. Nov. 15, 2014 - BusinessWire - BZX
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global Operations Officer, in January 2015 6:30 a.m. Nov. 10, 2014 - BusinessWire - BZX
Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the Effectiveness of Soliris® (eculizumab) Treatment at ASH 2014 Annual Meeting 4:16 p.m. Nov. 6, 2014 - BusinessWire - BZX
Neurotrope Appoints Warren W. Wasiewski, M.D. as Executive Vice President, Development and Chief Medical Officer 8:30 a.m. Nov. 6, 2014 - PR Newswire - PRF
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Alexion Launches Every Day with HPP™ Campaign in Support of Hypophosphatasia (HPP) Awareness Week 4:51 p.m. Oct. 27, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 9:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
Researchers to Present Data on Soliris® (eculizumab) as a Treatment for Patients with aHUS at ASN 2014 Annual Meeting 4:15 p.m. Oct. 23, 2014 - BusinessWire - BZX
Collaborations, Dividends, New Drug Applications, and Technical Updates - Research Reports on Simon, Regions Financial, American Capital, CareFusion and Alexion 9:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Critical Alerts For Sears Holdings, JetBlue, Qlogic, Las Vegas Sands and Alexion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 15, 2014 - PR Newswire - PRF
Alexion Submits NDA in Japan for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:30 a.m. Oct. 15, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Third Quarter 2014 Results on Thursday, October 23, 2014 10:00 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Board of Directors Appoints New Chairman and Creates the New Position of Lead Independent Director 6:30 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Announces the Passing of Max Link, Ph.D., Chairman of the Company’s Board of Directors 4:00 p.m. Oct. 7, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼